Saved report copy
Recorded
AI companies turn to healthcare amid backlash and pressure to prove benefits
AI companies are expanding into healthcare and drug discovery as they seek new revenue while countering public concerns about data centers, jobs, costs and environmental impacts, Axios reports. Anthropic, Nvidia, Eli Lilly and Google’s Isomorphic Labs are pursuing investments or collaborations, though major medical breakthroughs may remain years away. The sector also faces concerns about affordability, safety, privacy and the potential misuse of AI-enabled biological research.